Human T-cell leukemia virus type I Tax transactivates the matrix metalloproteinase-9 gene: potential role in mediating adult T-cell leukemia invasiveness.
暂无分享,去创建一个
M. Tomonaga | N. Mori | N. Yamamoto | S. Morikawa | Hiroshi Sato | R. Geleziunas | Yasuaki Yamada | S. Kamihira | M. Senba | Tomayoshi Hayashi | T. Hayashibara | S. Ikeda | Y. Yamasaki
[1] D. Schwartz,et al. Tumor invasion and host extracellular matrix , 2004, Cancer and Metastasis Reviews.
[2] R. Szymocha,et al. T Lymphocytes Activated by Persistent Viral Infection Differentially Modify the Expression of Metalloproteinases and Their Endogenous Inhibitors, TIMPs, in Human Astrocytes: Relevance to HTLV-I-Induced Neurological Disease1 , 2000, The Journal of Immunology.
[3] S. Santavirta,et al. Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: different profiles in trauma and rheumatoid arthritis , 1999, Annals of the rheumatic diseases.
[4] M. Tomonaga,et al. Expression of human inducible nitric oxide synthase gene in T-cell lines infected with human T-cell leukemia virus type-I and primary adult T-cell leukemia cells. , 1999, Blood.
[5] E. Harhaj,et al. IKKγ Serves as a Docking Subunit of the IκB Kinase (IKK) and Mediates Interaction of IKK with the Human T-cell Leukemia Virus Tax Protein* , 1999, The Journal of Biological Chemistry.
[6] K. Jeang,et al. Role of Adapter Function in Oncoprotein-mediated Activation of NF-κB , 1999, The Journal of Biological Chemistry.
[7] D. Ballard,et al. IKKγ Mediates the Interaction of Cellular IκB Kinases with the Tax Transforming Protein of Human T Cell Leukemia Virus Type 1* , 1999, The Journal of Biological Chemistry.
[8] A. Kossakowska,et al. Expression of matrix metalloproteinases (MMP‐2 and ‐9) and tissue inhibitors of metalloproteinases (TIMP‐1 and ‐2) in acute myelogenous leukaemia blasts: comparison with normal bone marrow cells , 1999, British journal of haematology.
[9] M. Tomonaga,et al. Constitutive Activation of NF-κB in Primary Adult T-Cell Leukemia Cells , 1999 .
[10] M. Tomonaga,et al. Constitutive Activation Of Nf- κ B In Primary Adult T-cell Leukemia Cells , 1999 .
[11] W. Greene,et al. Human T-Cell Leukemia Virus Type 1 Tax Induction of NF-κB Involves Activation of the IκB Kinase α (IKKα) and IKKβ Cellular Kinases , 1998, Molecular and Cellular Biology.
[12] Y. Okada,et al. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in HTLV-I-associated myelopathy. , 1998, Journal of neuropathology and experimental neurology.
[13] A. Kossakowska,et al. Proteolytic activity of human non-Hodgkin's lymphomas. , 1998, The American journal of pathology.
[14] A. Matsuzaki,et al. Expression of the active form of MMP-2 on the surface of leukemic cells accounts for their in vitro invasion , 1998, Journal of Cancer Research and Clinical Oncology.
[15] David M. Rothwarf,et al. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB , 1997, Nature.
[16] K. Matsumoto,et al. Human T-cell leukemia virus type 1 Tax protein transforms rat fibroblasts via two distinct pathways , 1997, Journal of virology.
[17] G. Marti,et al. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in reactive and neoplastic lymphoid cells. , 1997, Blood.
[18] T. McKinsey,et al. Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB , 1996, Molecular and cellular biology.
[19] R. Giavazzi,et al. Matrix metalloproteinase inhibition: a review of anti-tumour activity. , 1995, Annals of oncology : official journal of the European Society for Medical Oncology.
[20] K. Yoshino,et al. Metalloproteinase-mediated Release of Human Fas Ligand , 1995 .
[21] T. McKinsey,et al. Coupling of a signal response domain in I kappa B alpha to multiple pathways for NF-kappa B activation , 1995, Molecular and cellular biology.
[22] E. Kohn,et al. Molecular insights into cancer invasion: strategies for prevention and intervention. , 1995, Cancer research.
[23] T. McKinsey,et al. Coupling of a Signal Response Domain in IkBato Multiple Pathways for NF-kB Activation , 1995 .
[24] A. H. Drummond,et al. Processing of tumour necrosis factor-α precursor by metalloproteinases , 1994, Nature.
[25] W. Stetler-Stevenson,et al. Quantitative zymography: detection of picogram quantities of gelatinases. , 1994, Analytical biochemistry.
[26] H. Birkedal‐Hansen,et al. Comparative sequence specificities of human 72- and 92-kDa gelatinases (type IV collagenases) and PUMP (matrilysin). , 1993, Biochemistry.
[27] H. Sato,et al. Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. , 1993, Oncogene.
[28] J. O'Connell,et al. The matrix metalloproteinases and their natural inhibitors: prospects for treating degenerative tissue diseases. , 1992, Trends in biotechnology.
[29] L. Chow,et al. Complete structure of the human gene for 92-kDa type IV collagenase. Divergent regulation of expression for the 92- and 72-kilodalton enzyme genes in HT-1080 cells. , 1991, The Journal of biological chemistry.
[30] W. Greene,et al. Identification of HTLV-I tax trans-activator mutants exhibiting novel transcriptional phenotypes. , 1990, Genes & development.
[31] L. Chow,et al. Structure of the human type IV collagenase gene. , 1990, The Journal of biological chemistry.
[32] K. Sugamura,et al. Activation of endogenous c-fos proto-oncogene expression by human T-cell leukemia virus type I-encoded p40tax protein in the human T-cell line, Jurkat , 1989, Journal of virology.
[33] K. Sugamura,et al. Electroporation: application to human lymphoid cell lines for stable introduction of a transactivator gene of human T-cell leukemia virus type I. , 1989, Nucleic acids research.
[34] D. Rifkin,et al. Membrane and matrix localization of proteinases: a common theme in tumor cell invasion and angiogenesis. , 1988, Biochimica et biophysica acta.
[35] T. Harada,et al. IL‐2‐ and IL‐2‐R‐ independent proliferation of T‐cell lines from adult T‐cell leukemia/lymphoma patients , 1986, International journal of cancer.
[36] Mitsuhiro Osame,et al. HTLV-I ASSOCIATED MYELOPATHY, A NEW CLINICAL ENTITY , 1986, The Lancet.
[37] H. Strander. Interferon treatment of human neoplasia. , 1986, Advances in cancer research.
[38] L. Liotta. Tumor invasion and metastases--role of the extracellular matrix: Rhoads Memorial Award lecture. , 1986, Cancer research.
[39] F. Barin,et al. ANTIBODIES TO HUMAN T-LYMPHOTROPIC VIRUS TYPE-I IN PATIENTS WITH TROPICAL SPASTIC PARAPARESIS , 1985, The Lancet.
[40] M. Yoshida,et al. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[41] John D. Minna,et al. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma , 1980, Proceedings of the National Academy of Sciences.
[42] K. Miyamoto,et al. A novel T-cell line derived from adult T-cell leukemia. , 1980, Gan.
[43] H. Towler,et al. Adult T-cell leukemia : antigen in an ATL cell line and detection of antibodies to the antigen in human sera , 2022 .